Essais Glucose Transporter GLUT1

6 produits

Glucose Transporter GLUT1 est un gène codé par le symbole SLC2A1. Communément appelé aussi: Solute carrier family 2, facilitated glucose transporter member 1; Glucose transporter type 1, erythrocyte/brain; GLUT-1; HepG2 glucose transporter; SLC2A1; GLUT1. Glucose Transporter GLUT1 a une masse de 54.08kDa, une longueur d'acide aminé de 492, et est impliqué dans les maladies: GLUT1 deficiency syndrome 1; GLUT1 deficiency syndrome 2; Epilepsy, idiopathic generalized 12; Dystonia 9; Stomatin-deficient cryohydrocytosis with neurologic defects.

Nous proposons 6 Glucose Transporter GLUT1 kits ELISA pour la détection qualitative ou quantitative de Glucose Transporter GLUT1 à partir d'échantillons Humain, Souris et Rat.

Informations sur les Gènes et les Protéines

Résumé UniProt
Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed:18245775, PubMed:19449892, PubMed:25982116, PubMed:27078104, PubMed:10227690). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed:18245775, PubMed:19449892). Most important energy carrier of the brain: present at the blood-brain barrier and assures the energy-independent, facilitative transport of glucose into the brain (PubMed:10227690).
Résumé Entrez
This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia.
Spécificité tissulaire
Detected in erythrocytes (at protein level). Expressed at variable levels in many human tissues.
Implication dans la maladie
GLUT1 deficiency syndrome 1: A neurologic disorder showing wide phenotypic variability. The most severe 'classic' phenotype comprises infantile-onset epileptic encephalopathy associated with delayed development, acquired microcephaly, motor incoordination, and spasticity. Onset of seizures, usually characterized by apneic episodes, staring spells, and episodic eye movements, occurs within the first 4 months of life. Other paroxysmal findings include intermittent ataxia, confusion, lethargy, sleep disturbance, and headache. Varying degrees of cognitive impairment can occur, ranging from learning disabilities to severe mental retardation.

GLUT1 deficiency syndrome 2: A clinically variable disorder characterized primarily by onset in childhood of paroxysmal exercise-induced dyskinesia. The dyskinesia involves transient abnormal involuntary movements, such as dystonia and choreoathetosis, induced by exercise or exertion, and affecting the exercised limbs. Some patients may also have epilepsy, most commonly childhood absence epilepsy. Mild mental retardation may also occur. In some patients involuntary exertion-induced dystonic, choreoathetotic, and ballistic movements may be associated with macrocytic hemolytic anemia.

Epilepsy, idiopathic generalized 12: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. In some EIG12 patients seizures may remit with age.

Dystonia 9: An autosomal dominant neurologic disorder characterized by childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia. Most patients show some degree of cognitive impairment. Other variable features may include seizures, migraine headaches, and ataxia.

Stomatin-deficient cryohydrocytosis with neurologic defects: A rare form of stomatocytosis characterized by episodic hemolytic anemia, cold-induced red cells cation leak, erratic hyperkalemia, neonatal hyperbilirubinemia, hepatosplenomegaly, cataracts, seizures, mental retardation, and movement disorder.
Similitudes de séquence
Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily.
Modification post-traductionnelle
Phosphorylation at Ser-226 by PKC promotes glucose uptake by increasing cell membrane localization.
Localisation cellulaire
Cell membrane. Melanosome.

Localizes primarily at the cell surface (PubMed:18245775, PubMed:19449892, PubMed:23219802, PubMed:25982116, PubMed:24847886). Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065).
Standard Curve - Rat Glucose Transporter GLUT1 ELISA Kit (A78791) - Antibodies.com
Standard Curve - Human Glucose Transporter GLUT1 ELISA Kit (A75841) - Antibodies.com
Standard Curve - Mouse Glucose Transporter GLUT1 ELISA Kit (A75437) - Antibodies.com
Western Blot - GLUT1 Cell Based ELISA Kit (CB5299) - Antibodies.com
(4)
Standard Curve - Rat Glucose Transporter 1 ELISA Kit (DL-GLUT1-Ra) - Antibodies.com
Standard Curve - Human Glucose Transporter 1 ELISA Kit (DL-GLUT1-Hu) - Antibodies.com

Affichage de 1-6 sur 6 produits

Filtres Menu Principal Nous Contacter 0Caisse
Haut